Government policies and regulations have created an environment hostile to research and innovation.
pmprb
July 29, 2021
12:02PM
Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.
July 20, 2021
10:38AM
Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.
July 13, 2021
1:05PM
Accepting FDA approvals could lead to earlier marketing availability in Canada.
June 3, 2021
9:29AM
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
June 8, 2020
9:54AM
Planned changes would likely result in fewer new and innovative drugs available to Canadians.
August 14, 2019
7:40PM
Forcing manufacturers of high-cost drugs to reduce their prices by up to 80 per cent is unsustainable.
January 24, 2019
1:00AM
July 20, 2018
1:00AM
